Results
|
|
101.
|
|
|
|
102.
|
|
|
|
103.
|
|
|
|
104.
|
|
|
|
105.
|
|
|
|
106.
|
|
|
|
107.
|
|
|
|
108.
|
|
|
|
109.
|
|
|
|
110.
|
|
|
|
111.
|
|
|
|
112.
|
|
|
|
113.
|
Fulvestrant plus goserelin versus anastrozole plus goserelin versus goserelin alone for hormone receptor-positive, HER2-negative tamoxifen-pretreated premenopausal women with recurrent or metastatic breast cancer (KCSG BR10-04): a multicentre, open-label, three-arm, randomised phase II trial (FLAG study). [electronic resource] by
- Kim, Ji-Yeon
- Im, Seock-Ah
- Jung, Kyung Hae
- Ro, Jungsil
- Sohn, Joohyuk
- Kim, Jee Hyun
- Park, Yeon Hee
- Kim, Tae-Yong
- Kim, Sung-Bae
- Lee, Keun Seok
- Kim, Gun Min
- Kim, Se Hyun
- Kim, Seonwoo
- Ahn, Jin Seok
- Lee, Kyung-Hun
- Ahn, Jin-Hee
- Park, In Hae
- Im, Young-Hyuck
Producer: 20190520
In:
European journal of cancer (Oxford, England : 1990) vol. 103
Availability: No items available.
|
|
|
114.
|
Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer. [electronic resource] by
- Gelmon, Karen A
- Cristofanilli, Massimo
- Rugo, Hope S
- DeMichele, Angela M
- Joy, Anil A
- Castrellon, Aurelio
- Sleckman, Bethany
- Mori, Ave
- Theall, Kathy Puyana
- Lu, Dongrui R
- Huang, Xin
- Bananis, Eustratios
- Finn, Richard S
- Slamon, Dennis J
Producer: 20210617
In:
The breast journal vol. 26
Availability: No items available.
|
|
|
115.
|
|
|
|
116.
|
|
|
|
117.
|
|
|
|
118.
|
|
|
|
119.
|
|
|
|
120.
|
|